Scrambled shRNA with mCherry co-expression Adenovirus
Holiday Sale
This adenovirus contains a scramble shRNA sequence under the control of U6 promoter, with mCherry co-expression under a CMV promoter.
It can be used for as the control for gene-targeting shRNA adenovirus.
1781
Ad-U6-shRNA-mCherry
Ready-to-use Scrambled shRNA with mCherry co-expression Adenovirus. RNAi shRNA control adenovirus mCherry scramble 1781
Original price was: $475.00.$403.75Current price is: $403.75.
Recently Viewed Products
Ad-CMV-iCre
Cat No: 1045
Ad-CMV-Caspase 9 (DN)
Cat No: 1044
Ad-CMV-Rb
Cat No: 1043
Ad-CMV-p27
Cat No: 1042
About Storage Conditions
All our viral products should be kept at -80°C. At this temperature, the virus will remain stable for 6-12 months (and in some cases, up to 2 years). Once thawed, the product can be stored at 4°C for 2-3 weeks without significant loss of biological activity.
We recommend aliquoting your vectors into low protein binding tubes upon receipt. This helps avoid repeated freeze-thaw cycles, as well as prevent loss of virus. To maintain accurate titer, aliquot in at least 20ul per tube.
Related Products
Ad-U6-shRNA-CFP
Cat No: 1780
Original price was: $475.00.$403.75Current price is: $403.75.
Ad-U6-shRNA-RFP
Cat No: 1782
Original price was: $475.00.$403.75Current price is: $403.75.
Ad-U6-shRNA-YFP
Cat No: 1783
Original price was: $475.00.$403.75Current price is: $403.75.
Ad-U6-RNAi
Cat No: 1640
Original price was: $475.00.$403.75Current price is: $403.75.
Ad-CMV-RNAi
Cat No: 1641
Original price was: $475.00.$403.75Current price is: $403.75.
Control Products
Ad-U6-shRNA-CFP
Cat No: 1780
Original price was: $475.00.$403.75Current price is: $403.75.
Ad-U6-shRNA-RFP
Cat No: 1782
Original price was: $475.00.$403.75Current price is: $403.75.
Ad-U6-shRNA-YFP
Cat No: 1783
Original price was: $475.00.$403.75Current price is: $403.75.
Ad-U6-RNAi
Cat No: 1640
Original price was: $475.00.$403.75Current price is: $403.75.
Ad-GFP-U6-shRNA
Cat No: 1122
Original price was: $475.00.$403.75Current price is: $403.75.
